Charles Schwab’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Charles Schwab’s Portfolio AUXL Stock Details AUXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-143,086	Closed	-$4.92M	–	3119
2014 Q4	$4.92M	Buy	143,086 +9,004	+7%	+$294K	0.01%	1463
2014 Q3	$4M	Buy	134,082 +2,793	+2%	+$59.2K	0.01%	1552
2014 Q2	$2.63M	Sell	131,289 -378	-0.3%	-$8.67K	﹤0.01%	1834
2014 Q1	$3.58M	Buy	131,667 +4,543	+4%	+$121K	0.01%	1590
2013 Q4	$2.64M	Buy	127,124 +4,507	+4%	+$85K	0.01%	1733
2013 Q3	$2.21M	Buy	122,617 +7,216	+6%	+$130K	﹤0.01%	1782
2013 Q2	$1.97M	Buy	+115,401	New	+$1.84M	﹤0.01%	1764

Other funds holding AUXL

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Charles Schwab's AUXL Position: Q1 2015 in Review

Charles Schwab sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 143,086 shares — an estimated $4.92M sold.

Charles Schwab first reported a position in AUXL in Q2 2013 and held it in 7 quarters. The position peaked at $4.92M in Q4 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

Charles Schwab reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
Charles Schwab sold 143,086 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $4.92M.
Charles Schwab first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 7 quarters.
Charles Schwab's AUXILIUM PHARAMCEUTICALS INC position peaked at $4.92M in Q4 2014.
1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on Charles Schwab's 13F filing for Q1 2015, filed 14 May 2015.